scispace - formally typeset
I

Ik-Kyung Jang

Researcher at Harvard University

Publications -  427
Citations -  26768

Ik-Kyung Jang is an academic researcher from Harvard University. The author has contributed to research in topics: Myocardial infarction & Intravascular ultrasound. The author has an hindex of 73, co-authored 404 publications receiving 24255 citations. Previous affiliations of Ik-Kyung Jang include Katholieke Universiteit Leuven & Hospital General Universitario Gregorio Marañón.

Papers
More filters
Journal ArticleDOI

Trombocitopenia inducida por heparina

TL;DR: En esta revision se discute los aspectos diagnosticos y el manejo de este sindrome, y una vez que se confirma serologicamente el diagnostico de TIH o la sospecha es alta, se debe suspender el tratamiento con heparina y valorar el tratsmano con anticoagulantes alternativos.
Journal ArticleDOI

The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.

TL;DR: It is suggested that incomplete NSC and the prevalence of latent thrombus within the SES segments did not decrease from 2 to 5 years, and the risk of stent thrombosis related to incomplete healing of SES may continue for an extended period.
Journal ArticleDOI

Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization

TL;DR: The prevalence of antibodies to PF4/heparin is low in the population presenting for cardiac catheterization, however, a significant proportion of patients develop antibodies toPF4/Heparin after a small exposure to heparin duringCatheterization.
Journal ArticleDOI

Clinical Predictors for Lack of Favorable Vascular Response to Statin Therapy in Patients With Coronary Artery Disease: A Serial Optical Coherence Tomography Study.

TL;DR: Chronic kidney disease is an independent predictor for the lack of a favorable vascular response to statin therapy, whereas acute coronary syndrome is anindependent predictor for favorable vascular Response to Statin therapy.